Skip to content

Rijavithi Viral and Mycobacterium PCR Arrays in CNS Infection Study

Cerebrospinal Fluid Polymerase Chain Reaction Arrays for Central Nervous System Neurotropic Viral Infection and Mycobacterium Infection Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00807378
Acronym
VIMPAC
Enrollment
200
Registered
2008-12-11
Start date
2008-07-31
Completion date
2010-03-31
Last updated
2010-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CNS Viral Infection

Keywords

CNS viral infection, PCR, HYBRIDIZATION

Brief summary

This study of neurotropic viral infection and Tuberculous CNS infection is the comprehensive investigation of CSF PCR arrays (Hybrydiaztion technique,Sybergreen and Taqman real time PCR arrays of CSF ) in suspected cases of viral CNS infection, Tuberculous CNS infection in both AIDS and non AIDS patients. Patients with clinical viral encephalitis and all meningoencephalitis including all patients with HIV/AIDS CSF and non AIDS will be banked and test for RNA and DNA viral sequence by Real time PCR arrays and IS6110 gene of Mycobacterium tuberculosis. Clinical data and final diagnosis will be used to analyze the result of this PCR arrays technique compared to clinical gold standard criteria.

Interventions

OTHERLUMBAR PUNCTURE

LUMBAR PUNCTURE FFOR CSF COLLECTION

Sponsors

Rajavithi Biomolecular Research Center
CollaboratorOTHER
Department of Medical Services Ministry of Public Health of Thailand
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. AGE MORE THAN 15 YRS 2. ABLE TO INFORM CONSENT BY THEMSELF OR THEIR PARENT 3. SUSPECTED CNS VIRAL INFECTION

Exclusion criteria

1. UNABLE/CONTRAINDICATED FOR LUMBAR PUNCTURE OR CSF COLLECTION 2. WITHDRAW CONSENT 3. SUSPECTED SEVERE OR VILURENT VIRAL INFECTION SUCH AS H5N1/SARS INFECTION

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026